Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cellular Diagnosis, Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06469138
What this trial is testing

Investigate 14C-bemcentinib in Healthy Male Subjects

Who this might be right for
Non-Small Cell Lung CancerMetastatic MelanomaAcute Myeloid Leukemia+5 more
BerGenBio ASA 6
Early research (Phase 1)Ended earlyNCT00739609
What this trial is testing

IDO Inhibitor Study for Relapsed or Refractory Solid Tumors

Who this might be right for
Breast CancerLung CancerMelanoma+2 more
NewLink Genetics Corporation 17
Early research (Phase 1)Study completedNCT00836407
What this trial is testing

Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Testing effectiveness (Phase 2)Study completedNCT00534001
What this trial is testing

Bupropion in Helping Adults Stop Smoking

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Roswell Park Cancer Institute 95
Very early researchEnded earlyNCT03890198
What this trial is testing

LCAR-C182A Cells in the Treatment of Advanced Gastric Cancer and Pancreatic Ductal Adenocarcinoma

Who this might be right for
Gastric CancerPancreatic Ductal Adenocarcinoma
First Affiliated Hospital Xi'an Jiaotong University 2
Early research (Phase 1)Ended earlyNCT00003434
What this trial is testing

Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Duke University 8
Early research (Phase 1)Active Not RecruitingNCT05163028
What this trial is testing

A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

Who this might be right for
Non Small Cell Lung CancerColorectal CancerPancreatic Cancer+4 more
HUYABIO International, LLC. 42
Not applicableStudy completedNCT00684801
What this trial is testing

Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers

Who this might be right for
Colorectal CancerLung CancerOvarian Cancer+1 more
Case Comprehensive Cancer Center 605
Testing effectiveness (Phase 2)WithdrawnNCT00003514
What this trial is testing

Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy

Who this might be right for
Merkel Cell CarcinomaIslet Cell CarcinomaNeuroendocrine Carcinoma+1 more
Burzynski Research Institute
Testing effectiveness (Phase 2)Study completedNCT00427349
What this trial is testing

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic Syndrome
Eastern Cooperative Oncology Group 46
Early research (Phase 1)Not Yet RecruitingNCT07828236
What this trial is testing

PHASE 1 TRIAL OF Lm-LLO-TT AND GEMCITABINE IN UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA

Who this might be right for
Pancreas Cancer, Duct Cell AdenocarcinomaPancreatic CancerAdvanced Pancreatic Adenocarcinoma
Loki Therapeutics, Inc. 18
Early research (Phase 1)Ended earlyNCT06466187
What this trial is testing

SGN-MesoC2 in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungOvarian NeoplasmsPancreatic Adenocarcinoma+4 more
Seagen, a wholly owned subsidiary of Pfizer 19
Testing effectiveness (Phase 2)Looking for participantsNCT06506643
What this trial is testing

Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms

Who this might be right for
CLLSolid Tumor, Adult
Vector Vitale LLC 36
Testing effectiveness (Phase 2)Study completedNCT01024387
What this trial is testing

AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorCarcinoid TumorPancreatic Neuroendocrine Tumor
Dana-Farber Cancer Institute 60
Testing effectiveness (Phase 2)Study completedNCT02178436
What this trial is testing

Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasStage IV Pancreatic Cancer
Mohammed Najeeb Al Hallak 15
Not applicableStudy completedNCT07704021
What this trial is testing

Safety and Efficacy of EUS-guided Gallbladder Drainage Under Endoscopist-directed Conscious Sedation

Who this might be right for
Cholecystitis, AcutePancreas Cancer, Duct Cell AdenocarcinomaCholangiocarcinoma
Azienda Unita Sanitaria Locale di Piacenza 48
Not applicableUnknownNCT06342323
What this trial is testing

The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy

Who this might be right for
Lung CancerLiver CancerPancreatic Cancer+1 more
Peking University Third Hospital 57
Testing effectiveness (Phase 2)Study completedNCT05259696
What this trial is testing

Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)

Who this might be right for
OncologyMelanomaOvarian Cancer+14 more
Palleon Pharmaceuticals, Inc. 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT05988918
What this trial is testing

Multicenter Trial of ESK981 in Patients With Select Solid Tumors

Who this might be right for
Pancreatic AdenocarcinomaAdenosquamous CarcinomaPancreatic Neuroendocrine Tumor+4 more
University of Michigan Rogel Cancer Center 17
Testing effectiveness (Phase 2)Study completedNCT03989115
What this trial is testing

Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC

Who this might be right for
Solid Tumor
Revolution Medicines, Inc. 113
Next Page